Tabouret E, Furtner J, Graillon T, Silvani A, Le Rhun E, Soffietti R, Lombardi G, Sepúlveda-Sánchez JM, Brandal P, Bendszus M, Golfinopoulos V, Gorlia T, Weller M, Sahm F, Wick W, Preusser M(2024) 3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas Neuro Oncol(in press) DOI 10.1093/neuonc/noae037, PubMed 38452246
Blakstad H, Brekke J, Rahman MA, Arnesen VS, Miletic H, Brandal P, Lie SA, Chekenya M, Goplen D(2023) Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions PLoS One, 18(2), e0281166 DOI 10.1371/journal.pone.0281166, PubMed 36730349
Blakstad H, Mendoza Mireles EE, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Vik-Mo EO, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Brandal P(2023) Incidence and outcome of pseudoprogression after radiation therapy in glioblastoma patients: A cohort study Neurooncol Pract, 11(1), 36-45 DOI 10.1093/nop/npad063, PubMed 38222046